Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
CHICAGO TAP Pharmaceutical Products said it has pulled the TV portion of its campaign for heartburn drug Prevacid “to focus on print media that it hopes will better explain the drug’s potential side effects and health risks.”
The Lake Forest, Ill.-based drug maker (a joint venture of Abbott Laboratories and Takeda Pharmaceutical Co. in Japan) had aired TV spots with NFL Hall of Fame quarterback John Elway.
The lead agency is Merkley + Partners in New York.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in